Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00898547
What this trial is testing

Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05425576
What this trial is testing

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

Who this might be right for
Malignant Pleural Mesothelioma
Oncotelic Inc. 63
Testing effectiveness (Phase 2)Looking for participantsNCT06875076
What this trial is testing

Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma

Who this might be right for
Pretreated Pleural Mesothelioma
The First Hospital of Jilin University 25
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Looking for participantsNCT05647265
What this trial is testing

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Who this might be right for
Pleural Biphasic MesotheliomaPleural Sarcomatoid Mesothelioma
Alliance for Clinical Trials in Oncology 26
Testing effectiveness (Phase 2)Looking for participantsNCT05960773
What this trial is testing

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Who this might be right for
MesotheliomaMalignant Mesothelioma (MM)Early-stage Mesothelioma+3 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06057935
What this trial is testing

Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Who this might be right for
Malignant Peritoneal MesotheliomaPeritoneal MesotheliomaMesothelioma+2 more
Memorial Sloan Kettering Cancer Center 64
Early research (Phase 1)Study completedNCT03678350
What this trial is testing

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Who this might be right for
Malignant MesotheliomaNon-Small Cell Lung CarcinomaPleural Disorder
Roswell Park Cancer Institute 9
Early research (Phase 1)Looking for participantsNCT05873686
What this trial is testing

Clinical Study of NXP900 in Subjects With Advanced Cancers

Who this might be right for
Advanced Solid TumorNSCLC (Non-small Cell Lung Cancer)Renal Cancer+3 more
Nuvectis Pharma, Inc. 140
Testing effectiveness (Phase 2)Study completedNCT00027703
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 106
Testing effectiveness (Phase 2)Study completedNCT00484276
What this trial is testing

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 57
Early research (Phase 1)Study completedNCT00652574
What this trial is testing

Dasatinib in Resectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
M.D. Anderson Cancer Center 56
Testing effectiveness (Phase 2)Study completedNCT02347917
What this trial is testing

BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural MesotheliomaNon-Small Cell Lung Cancer
Sumitomo Pharma Co., Ltd. 28
Testing effectiveness (Phase 2)Study completedNCT02151448
What this trial is testing

ΑDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

Who this might be right for
Malignant Neoplasm of Pancreas Metastatic to Peritoneal SurfaceMalignant Peritoneal MesotheliomaPeritoneal Carcinomatosis
David Bartlett 64
Testing effectiveness (Phase 2)Ended earlyNCT00027508
What this trial is testing

Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
PharmaMar
Not applicableStudy completedNCT03068117
What this trial is testing

Malignant Mesothelioma - Can we Improve Quality of Life

Who this might be right for
Mesothelioma, Malignant
Portsmouth Hospitals NHS Trust 319
Testing effectiveness (Phase 2)Ended earlyNCT01624090
What this trial is testing

Mithramycin for Lung, Esophagus, and Other Chest Cancers

Who this might be right for
Lung CancerEsophageal CancerMesothelioma+2 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Ended earlyNCT06034860
What this trial is testing

Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

Who this might be right for
Non Small Cell Lung CancerHepatocellular CarcinomaMelanoma+8 more
Molecular Templates, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00190762
What this trial is testing

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 240
Testing effectiveness (Phase 2)Study completedNCT00017186
What this trial is testing

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 69
Next Page